Meinolf Thiemann

VP Preclinical Development at Apogenix

Meinolf Thiemann is currently the VP Preclinical Development at Apogenix GmbH, where Meinolf manages research and development activities and supports clinical development. Prior to this role, Meinolf held positions at Santhera Pharmaceuticals as the Head of Assay Development, focusing on setting up biochemical protein assays for drug discovery. Meinolf Thiemann holds a Dr. rer. nat. in Biochemistry and Cell Biology from Heidelberg University and a Master's degree in Biology from Bielefeld University.

Location

Schriesheim, Germany

Links


Org chart


Teams


Offices


Apogenix

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.


Employees

51-200

Links